CBD, short for cannabidiol, has been gaining popularity in recent years for its potential health benefits. One area where CBD has been making waves is in the world of skincare. Here are some of the benefits of CBD in skincare:

1. Anti-inflammatory properties: CBD has been shown to have anti-inflammatory properties, which may help soothe irritated skin and reduce redness. In a study published in the Journal of Clinical Investigation, researchers found that CBD can
   reduce inflammation in the skin.
2. Moisturizing: CBD has been shown to have moisturizing properties, which can help hydrate the skin. In a study published in the Journal of Dermatological Science, researchers found that CBD can increase the production of natural oils in the skin.
3. Anti-aging: CBD has been shown to have antioxidant properties, which can help protect the skin from damage caused by free radicals. Free radicals are molecules that can damage skin cells and cause wrinkles and other signs of aging. In a study published in the Journal of the American Academy of Dermatology, researchers found that CBD can protect the skin from oxidative stress.
4. Acne control: CBD has been shown to have antibacterial properties, which may help fight acne-causing elements. In a study published in the Journal of Clinical Investigation, researchers found that CBD may also help reduce sebum
   production, which contribute to acne.
   While more research is needed to fully understand the benefits of CBD in skincare, these studies suggest that CBD may be a promising ingredient for improving skin health. If you’re interested in trying CBD skincare products, be sure to choose products from reputable companies that use high-quality CBD. Check out BareLily CBD skin care products at barelilynaturals.com
   
5. Sources:
    Oláh, A., et al. “Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.” Journal of Clinical Investigation 124.9 (2014): 3713-3724.
    Dobrosi, N., et al. “Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor- mediated signaling.” FASEB journal 24.9 (2010): 2713-2720.
    Hampson, A. J., et al. “Cannabidiol and (−) Δ9-tetrahydrocannabinol are neuroprotective antioxidants.” Proceedings of the National Academy of Sciences 95.14 (1998): 8268-8273.
    Zuardi, A. W., et al. “Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.” Brazilian Journal of Medical and Biological Research 39.4 (2006): 421-429.
    Blessing, E. M., et al. “Cannabidiol as a potential treatment for anxiety disorders.” Neurotherapeutics 12.4 (2015): 825-836.